Skip to main content

December 2023 Vol 16, Payers' Guide to FDA Updates

Foreword
Welcome to another installment of the 2023 PAYERS’ GUIDE TO FDA UPDATES: Year-End Approvals, Upcoming Decisions
Read More
Expert Perspective
Prescription Drug Provisions in the Inflation Reduction Act of 2022: A Payer Perspective
Read More
In-Depth Drug Profile
FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management
Jerm Day-Storms, PhD, MWC
Read More
In-Depth Drug Profile
Exa-cel and Lovo-cel Provide Potential Functional Cure for Patients with SCD or TDT
Jerm Day-Storms, PhD, MWC
Read More
FDA Pipeline
Upcoming FDA Actions, January Through March 2024
Read More
FDA Approvals
Directory of FDA Approvals, August Through December 2023
Read More

Results 1 - 6 of 6